ConductScience.org, home

Paper33535978

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.

Zhang R and 8 others. BMC Cancer, 2021. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma. Papers, record 33535978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33535978

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
PubMed
Journal
BMC Cancer
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.13
iCite
Revised in PubMed
2022-12-07
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang RRui
2Li QQi
3Fu JJialu
4Jin ZZhechuan
5Su JJingbo
6Zhang JJian
7Chen CChen
8Geng ZZhimin
9Zhang DDonghttps://orcid.org/0000-0001-8254-7568

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Duct NeoplasmsMajor topic
Biomarkers, TumorMajor topic
CholangiocarcinomaMajor topic
Gene Expression Regulation, NeoplasticMajor topic
MutationMajor topic
NomogramsMajor topic
Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Gene Expression Profiling
Humans
Male
Middle Aged
Prognosis
Survival Rate
Exome Sequencing

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
62076194National Natural Science Foundation of ChinaPubMed
2017ZDXM-SF-055Key Research and Development Plan of Shaanxi ProvincePubMed
No. 2017KW-060Key Research and Development Plan of Shaanxi ProvincePubMed
No. 2020SF-070the General Project of Natural Science Basic Research Plan of Shaanxi ProvincePubMed
XJTU1AF-CRF-2018-022Clinical Research Fund of the First Affiliated Hospital of Xi'an Jiaotong UniversityPubMed

Source PubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126258846Genomic spectra of biliary tract cancer.Nat Genet2015https://conductscience.org/library/papers/26258846PubMed
225526346Mutational landscape of intrahepatic cholangiocarcinoma.Nat Commun2014https://conductscience.org/library/papers/25526346PubMed
331995247Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.J Surg Oncol2020https://conductscience.org/library/papers/31995247PubMed
428667006Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.Cancer Discov2017https://conductscience.org/library/papers/28667006PubMed
529337637Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine?J Clin Oncol2018https://conductscience.org/library/papers/29337637PubMed
632293336Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.BMC Cancer2020https://conductscience.org/library/papers/32293336PubMed
724718873Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.JAMA Surg2014https://conductscience.org/library/papers/24718873PubMed
829278425Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.Hepatology2018https://conductscience.org/library/papers/29278425PubMed
918234754Oncogenes and cancer.N Engl J Med2008https://conductscience.org/library/papers/18234754PubMed
1026059651Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.Ann Surg Oncol2016https://conductscience.org/library/papers/26059651PubMed
1129193010Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.Br J Surg2018https://conductscience.org/library/papers/29193010PubMed
1231700863Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.Ann Transl Med2019https://conductscience.org/library/papers/31700863PubMed
1329654927Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.J Thorac Oncol2018https://conductscience.org/library/papers/29654927PubMed
1426409434Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management.Cancer Lett2016https://conductscience.org/library/papers/26409434PubMed
1531337644Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer.Clin Cancer Res2019https://conductscience.org/library/papers/31337644PubMed
1630816954Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.JAMA Oncol2019https://conductscience.org/library/papers/30816954PubMed
1731038663Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.Ann Oncol2019https://conductscience.org/library/papers/31038663PubMed
1830526857Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.Elife2018https://conductscience.org/library/papers/30526857PubMed
1932606456Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Nat Rev Gastroenterol Hepatol2020https://conductscience.org/library/papers/32606456PubMed
2032256810Comprehensive genomic profile of cholangiocarcinomas in China.Oncol Lett2020https://conductscience.org/library/papers/32256810PubMed

See all 34 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42602860Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.eGastroenterology2026https://conductscience.org/library/papers/42602860PubMed
41514603A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma.Cancers (Basel)2025https://conductscience.org/library/papers/41514603PubMed
40831993NAT2: A Novel Target in Intrahepatic Cholangiocarcinoma and its Role in Modulating Tumor Behavior.Clin Med Insights Oncol2025https://conductscience.org/library/papers/40831993PubMed
39633593TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.Biomark Med2024https://conductscience.org/library/papers/39633593PubMed
38461467Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.J Gastroenterol2024https://conductscience.org/library/papers/38461467PubMed
38161496Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).J Clin Transl Hepatol2023https://conductscience.org/library/papers/38161496PubMed
37895447Targeted Therapies in Advanced Cholangiocarcinoma.Life (Basel)2023https://conductscience.org/library/papers/37895447PubMed
37626908Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis.Cells2023https://conductscience.org/library/papers/37626908PubMed
37434687Identification and evaluation of a risk model predicting the prognosis of breast cancer based on characteristic signatures.Transl Cancer Res2023https://conductscience.org/library/papers/37434687PubMed
36452508High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations.Front Oncol2022https://conductscience.org/library/papers/36452508PubMed
36290849Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.Curr Oncol2022https://conductscience.org/library/papers/36290849PubMed
35127895High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma.World J Clin Cases2022https://conductscience.org/library/papers/35127895PubMed
34947843Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma.Life (Basel)2021https://conductscience.org/library/papers/34947843PubMed
34282753Current Advances in Basic and Translational Research of Cholangiocarcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/34282753PubMed
34249744ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms.Front Oncol2021https://conductscience.org/library/papers/34249744PubMed

Download CSV of cited by

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AAK122848PubTator's text mininghttps://conductscience.org/library/genes/22848NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ANK2287PubTator's text mininghttps://conductscience.org/library/genes/287NCBI Gene
ANK3288PubTator's text mininghttps://conductscience.org/library/genes/288NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
CDC27996PubTator's text mininghttps://conductscience.org/library/genes/996NCBI Gene
CSMD3114788PubTator's text mininghttps://conductscience.org/library/genes/114788NCBI Gene
EPHA21969PubTator's text mininghttps://conductscience.org/library/genes/1969NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IPO53843PubTator's text mininghttps://conductscience.org/library/genes/3843NCBI Gene
KMT2D8085PubTator's text mininghttps://conductscience.org/library/genes/8085NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
LRP1B53353PubTator's text mininghttps://conductscience.org/library/genes/53353NCBI Gene
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025NCBI Gene
MUC24583PubTator's text mininghttps://conductscience.org/library/genes/4583NCBI Gene
NRAS4893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
OBSCN84033PubTator's text mininghttps://conductscience.org/library/genes/84033NCBI Gene
PBRM155193PubTator's text mininghttps://conductscience.org/library/genes/55193NCBI Gene
PCLO27445PubTator's text mininghttps://conductscience.org/library/genes/27445NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33535978

GET https://conductscience.org/api/papers/v1/33535978/references?page=2